{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:12:43Z","timestamp":1768079563995,"version":"3.49.0"},"reference-count":34,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of University and Research (MUR)","award":["CUP B53C24005980006"],"award-info":[{"award-number":["CUP B53C24005980006"]}]},{"name":"Italian Ministry of University and Research (MUR)","award":["18515 08\/10\/2024"],"award-info":[{"award-number":["18515 08\/10\/2024"]}]},{"name":"Italian Ministry of University and Research (MUR)","award":["PANOMIC"],"award-info":[{"award-number":["PANOMIC"]}]},{"name":"Italian Ministry of University and Research (MUR)","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}]},{"name":"Fondazione Pisa","award":["CUP B53C24005980006"],"award-info":[{"award-number":["CUP B53C24005980006"]}]},{"name":"Fondazione Pisa","award":["18515 08\/10\/2024"],"award-info":[{"award-number":["18515 08\/10\/2024"]}]},{"name":"Fondazione Pisa","award":["PANOMIC"],"award-info":[{"award-number":["PANOMIC"]}]},{"name":"Fondazione Pisa","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}]},{"name":"Dutch Cancer Society","award":["CUP B53C24005980006"],"award-info":[{"award-number":["CUP B53C24005980006"]}]},{"name":"Dutch Cancer Society","award":["18515 08\/10\/2024"],"award-info":[{"award-number":["18515 08\/10\/2024"]}]},{"name":"Dutch Cancer Society","award":["PANOMIC"],"award-info":[{"award-number":["PANOMIC"]}]},{"name":"Dutch Cancer Society","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}]},{"name":"AIRC","award":["CUP B53C24005980006"],"award-info":[{"award-number":["CUP B53C24005980006"]}]},{"name":"AIRC","award":["18515 08\/10\/2024"],"award-info":[{"award-number":["18515 08\/10\/2024"]}]},{"name":"AIRC","award":["PANOMIC"],"award-info":[{"award-number":["PANOMIC"]}]},{"name":"AIRC","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}]},{"name":"COST (European Cooperation in Science and Technology)","award":["CUP B53C24005980006"],"award-info":[{"award-number":["CUP B53C24005980006"]}]},{"name":"COST (European Cooperation in Science and Technology)","award":["18515 08\/10\/2024"],"award-info":[{"award-number":["18515 08\/10\/2024"]}]},{"name":"COST (European Cooperation in Science and Technology)","award":["PANOMIC"],"award-info":[{"award-number":["PANOMIC"]}]},{"name":"COST (European Cooperation in Science and Technology)","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies, with limited effective therapeutic options due to late diagnosis, aggressive progression, and rapid development of drug resistance. In pursuit of novel treatments, this study reports the design, synthesis, and biological evaluation of a new series of topsentin derivatives, featuring a 1,2,4-oxadiazole core. The newly synthesized derivatives were screened for antiproliferative activity against multiple PDAC cell lines (SUIT-2, Patu-T, and PANC-1), identifying several compounds with potent growth-inhibitory effects, particularly on SUIT-2 and Patu-T cells. Further studies demonstrated that these compounds also significantly inhibited cell migration and reduced clonogenic potential, with IC50 values in the micromolar range. The results suggest that these marine-inspired 1,2,4-oxadiazole derivatives effectively target key hallmarks of PDAC, including proliferation, migration, and colony formation, supporting their further development as promising candidates for overcoming drug resistance and metastatic progression in pancreatic cancer.<\/jats:p>","DOI":"10.3390\/md23080327","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T15:16:37Z","timestamp":1755184597000},"page":"327","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-0551","authenticated-orcid":false,"given":"Camilla","family":"Pecoraro","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Universit\u00e0 Degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-7023","authenticated-orcid":false,"given":"Daniela","family":"Carbone","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Universit\u00e0 Degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-6419","authenticated-orcid":false,"given":"Fares Hezam Mohammed","family":"Al Ostoot","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Universit\u00e0 Degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy"},{"name":"Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahrou","family":"Vahabi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Lencioni","sequence":"additional","affiliation":[{"name":"Cancer Pharmacology Laboratory, Fondazione Pisana per la Scienza, Via Ferruccio Giovannini 13, San Giuliano Terme, 56017 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4883-2004","authenticated-orcid":false,"given":"Patrizia","family":"Diana","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Universit\u00e0 Degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-7504","authenticated-orcid":false,"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"},{"name":"Cancer Pharmacology Laboratory, Fondazione Pisana per la Scienza, Via Ferruccio Giovannini 13, San Giuliano Terme, 56017 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-1579","authenticated-orcid":false,"given":"Barbara","family":"Parrino","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Universit\u00e0 Degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"36","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"39","author":"Ying","year":"2025","journal-title":"Genes Dev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bugazia, D., Al-Najjar, E., Esmail, A., Abdelrahim, S., Abboud, K., Abdelrahim, A., Umoru, G., Rayyan, H.A., Abudayyeh, A., and Al Moustafa, A.E. (2024). Pancreatic ductal adenocarcinoma: The latest on diagnosis, molecular profiling, and systemic treatments. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1386699"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Leroux, C., and Konstantinidou, G. (2021). Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology. Cancers, 13.","DOI":"10.3390\/cancers13040799"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semcancer.2024.09.002","article-title":"Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems","volume":"106\u2013107","author":"Lencioni","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chakkera, M., Foote, J.B., Farran, B., and Nagaraju, G.P. (2024). Breaking the stromal barrier in pancreatic cancer: Advances and challenges. Biochim. Biophys. Acta Rev. Cancer., 1879.","DOI":"10.1016\/j.bbcan.2023.189065"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2400050","DOI":"10.1200\/OA-24-00050","article-title":"Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment","volume":"1","author":"Finan","year":"2024","journal-title":"JCO Oncol. Adv."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, B., Zhang, Q., Castaneda, C., and Cook, S. (2024). Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine. Biomedicines, 12.","DOI":"10.3390\/biomedicines12102175"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101146","DOI":"10.1016\/j.drup.2024.101146","article-title":"Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma","volume":"77","author":"Shah","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.2174\/1871520622666220404082648","article-title":"Heterocyclic Compounds: Importance in Anticancer Drug Discovery","volume":"22","author":"Kumar","year":"2022","journal-title":"Anticancer. Agents Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Carbone, D., De Franco, M., Pecoraro, C., Bassani, D., Pavan, M., Cascioferro, S., Parrino, B., Cirrincione, G., Dall'Acqua, S., and Moro, S. (2024). Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043679"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Carbone, D., Pecoraro, C., Panzeca, G., Xu, G., Roeten, M.S.F., Cascioferro, S., Giovannetti, E., Diana, P., and Parrino, B. (2023). 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1. Mar. Drugs, 21.","DOI":"10.3390\/md21070412"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2018.12.049","article-title":"Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment","volume":"164","author":"Krasavin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11094-009-0264-5","article-title":"Synthesis, molecular docking, and biological testing of new selective inhibitors of glycogen synthase kinase 3\u03b2","volume":"43","author":"Ryzhova","year":"2009","journal-title":"Pharm. Chem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/0115734064278334231211054053","article-title":"Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery","volume":"20","author":"Biswas","year":"2024","journal-title":"Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/med.21852","article-title":"Expedition of sulfur-containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update","volume":"42","author":"Laxmikeshav","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1570179419666220509215722","article-title":"Recent Developments in the Synthesis and Anticancer Activity of Indole and Its Derivatives","volume":"20","author":"Kaur","year":"2023","journal-title":"Curr. Org. Synth."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Calcabrini, C., Catanzaro, E., Bishayee, A., Turrini, E., and Fimognari, C. (2017). Marine Sponge Natural Products with Anticancer Potential: An Updated Review. Mar. Drugs., 15.","DOI":"10.3390\/md15100310"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pecoraro, C., Terrana, F., Panzeca, G., Parrino, B., Cascioferro, S., Diana, P., Giovannetti, E., and Carbone, D. (2023). Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development. Molecules, 28.","DOI":"10.3390\/molecules28186450"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-2952(91)90031-Y","article-title":"Antitumor activity and biochemical effects of topsentin","volume":"42","author":"Burres","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"114233","DOI":"10.1016\/j.ejmech.2022.114233","article-title":"Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification","volume":"234","author":"Carbone","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102664","DOI":"10.1016\/j.isci.2021.102664","article-title":"CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin","volume":"24","author":"Parrino","year":"2021","journal-title":"iScience"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pecoraro, C., Parrino, B., Cascioferro, S., Puerta, A., Avan, A., Peters, G.J., Diana, P., Giovannetti, E., and Carbone, D. (2021). A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules, 27.","DOI":"10.3390\/molecules27010019"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7355_2013_29","article-title":"The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems","volume":"9","author":"Meanwell","year":"2014","journal-title":"Tactics Contemp. Drug Des."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jhet.177","article-title":"Synthesis, characterization, and antimicrobial activities of clubbed [1,2,4]-oxadiazoles with fluorobenzimidazoles","volume":"46","author":"Jadhav","year":"2009","journal-title":"J. Heterocycl. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Qunies, A.M., Spitznagel, B.D., Du, Y., David Weaver, C., and Emmitte, K.A. (2023). Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685. Bioorg. Med. Chem., 95.","DOI":"10.1016\/j.bmc.2023.117487"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pan.2024.06.004","article-title":"The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer","volume":"24","author":"Levine","year":"2024","journal-title":"Pancreatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14796694.2024.2435253","article-title":"Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: A systematic review","volume":"21","author":"Cockrum","year":"2025","journal-title":"Future Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ijrobp.2023.10.035","article-title":"Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells","volume":"118","author":"Che","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109852","DOI":"10.1016\/j.celrep.2021.109852","article-title":"Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer","volume":"37","author":"Lodestijn","year":"2024","journal-title":"Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Pfeifer, E., Burchell, J.M., Dazzi, F., Sarker, D., and Beatson, R. (2021). Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts. Cells, 10.","DOI":"10.3390\/cells10071653"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Daina, A., Michielin, O., and Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 7.","DOI":"10.1038\/srep42717"}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/23\/8\/327\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:11Z","timestamp":1760034431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/23\/8\/327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["md23080327"],"URL":"https:\/\/doi.org\/10.3390\/md23080327","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}